Literature DB >> 28709438

Surgical treatment for mediastinal abscess induced by endobronchial ultrasound-guided transbronchial needle aspiration: a case report and literature review.

Yujiro Yokoyama1, Takahiro Nakagomi1, Daichi Shikata1, Rumi Higuchi1, Toshio Oyama2, Taichiro Goto3.   

Abstract

BACKGROUND: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a useful and less invasive procedure for the definitive diagnosis of mediastinal and hilar lymph nodes. However, infectious complications can occur after EBUS-TBNA, although they are extremely rare. CASE
PRESENTATION: A 66-year-old man with necrotic and swollen lower paratracheal lymph nodes underwent EBUS-TBNA. A mediastinal abscess developed 9 days post-procedure. Surgical drainage and debridement of the abscess were performed along with lymph node biopsy followed by daily washing of the thoracic cavity. Surgical treatment was effective, leading to remission of the abscess. Biopsy revealed that the tumor was squamous cell carcinoma with no radiologically detected cancer elsewhere in the body. Mediastinal lung cancer was thus confirmed. Subsequent chemoradiotherapy led to the remission of the tumor.
CONCLUSIONS: Mediastinitis after EBUS-TBNA is rare but should be considered, particularly if the target lymph nodes are necrotic. Mediastinitis can lead to serious and rapid deterioration of the patient's condition, for which surgical intervention is the treatment of choice.

Entities:  

Keywords:  Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA); Lung cancer; Mediastinitis; Surgery

Mesh:

Year:  2017        PMID: 28709438      PMCID: PMC5513248          DOI: 10.1186/s12957-017-1206-4

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


Background

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive method that is now being widely performed to obtain specimens from mediastinal and hilar lesions [1]. It is a useful tool not only for the staging of lung cancer but also for the diagnosis of diseases such as sarcoidosis and metastatic malignancy [2]. Although complications associated with EBUS-TBNA are rare [3], infectious complications have been reported [4-15]. We report a case of mediastinitis resulting from an infection after EBUS-TBNA which we successfully treated with prompt surgical drainage. Furthermore, we review the literature regarding infective complications of EBUS-TBNA and propose a possible mechanism of pathogenesis.

Case presentation

A 66-year-old man was referred to our hospital for examination of swollen mediastinal lymph nodes. He was a current smoker with no significant past medical history. Computed tomography (CT) showed swelling of the lower paratracheal lymph nodes, with a maximum diameter of 48 mm; however, there were no pulmonary lesions (Fig. 1). EBUS-TBNA of the lymph nodes was performed with a total of 3 needle aspiration procedures under deep sedation by a well-trained bronchoscopist with 10 years’ experience in EBUS-TBNA. Prophylactic antibiotics were not administered, and there were no immediate complications. The patient was discharged without complications 1 day after the procedure (Fig. 2a). Histologic examination of the specimen detected only nonspecific inflammatory changes without any malignant or granulomatous findings.
Fig. 1

Chest CT before EBUS-TBNA showing swelling of the lower paratracheal lymph nodes. The lymph nodes are mostly necrotic

Fig. 2

Chest radiographs after EBUS-TBNA. a Chest radiograph 1 day after EBUS-TBNA. b A chest radiograph 9 days after EBUS-TBNA showing enlargement of the mediastinum, increased pleural effusion, and an infiltrative shadow in the right lower lung field

Chest CT before EBUS-TBNA showing swelling of the lower paratracheal lymph nodes. The lymph nodes are mostly necrotic Chest radiographs after EBUS-TBNA. a Chest radiograph 1 day after EBUS-TBNA. b A chest radiograph 9 days after EBUS-TBNA showing enlargement of the mediastinum, increased pleural effusion, and an infiltrative shadow in the right lower lung field Seven days after EBUS-TBNA, the patient experienced high fever and returned to our hospital. On admission, his symptoms included wheezing, right chest pain, and rapid breathing. The blood test results indicated infection: white cell count 9000/μL, C-reactive protein 33.58 mg/dL, and procalcitonin 50.76 ng/dL. The tumor markers, squamous cell carcinoma antigen (SCC) and cytokeratin-19 fragments (Cyfla), were elevated, being 5.2 and 3.9 ng/mL, respectively. Chest CT revealed right pleural effusion, enlargement of the lower paratracheal lymph nodes, and a multiloculated mediastinal abscess with gas production (Fig. 3). The patient was started on intravenous broad-spectrum antibiotics, which failed to improve his condition. A chest radiograph showed enlargement of the mediastinum, increased pleural effusion, and pneumonia in the right lower lung field (Fig. 2b); therefore, he was referred for surgical debridement and drainage along with lymph node dissection with curative intent. Nine days after EBUS-TBNA, surgery was performed via right posterolateral thoracotomy under general anesthesia. The intraoperative findings included fibrinopurulent fluid in the pleural cavity and mediastinum along with inflammatory swelling of the lymph nodes that rigidly adhered to the surrounding tissues. We decided that en bloc resection of the lymph nodes was not possible, so only a portion of these lymph nodes was biopsied. The thoracic cavity was washed with saline, and then a thoracic drain was inserted. Postoperatively, the patient remained critically ill with septic shock, and intrathoracic washing through the drain was started. Broad-spectrum antibiotics were continued as Streptococcus pneumoniae was isolated from multiple culture specimens of the debridement material. The patient’s general condition gradually improved, and he was discharged on antibiotics at 24 days post-procedure.
Fig. 3

CT imaging of mediastinitis. Chest CT, performed 7 days after EBUS-TBNA, shows enlargement of the lower paratracheal lymph nodes and gas production in the mediastinum along with the appearance of right pleural effusion

CT imaging of mediastinitis. Chest CT, performed 7 days after EBUS-TBNA, shows enlargement of the lower paratracheal lymph nodes and gas production in the mediastinum along with the appearance of right pleural effusion Pathological examination of the specimen revealed squamous cell carcinoma (Fig. 4), and the lesion was diagnosed as a mediastinal lung cancer because there were no primary cancer lesions elsewhere in the body. Thereafter, the patient received 6 courses of chemotherapy (carboplatin and nab-paclitaxel) with concurrent radiotherapy (70 Gy/35 Fr). The SCC and Cyfla levels returned to normal after chemoradiotherapy. Partial remission of the tumor was observed, and positron emission tomography showed no fluorodeoxyglucose uptake in these lesions (Fig. 5). The patient remains healthy without any progression of the disease 24 months after chemoradiotherapy.
Fig. 4

Histopathology of the biopsied specimen. The mediastinal lesion was diagnosed as squamous cell carcinoma. Scale bar, 40 μm

Fig. 5

Positron emission tomography after chemoradiotherapy showing no fluorodeoxyglucose uptake in the mediastinal lesion

Histopathology of the biopsied specimen. The mediastinal lesion was diagnosed as squamous cell carcinoma. Scale bar, 40 μm Positron emission tomography after chemoradiotherapy showing no fluorodeoxyglucose uptake in the mediastinal lesion

Discussion

EBUS-TBNA is a recently introduced, promising alternative to mediastinoscopy, which has been considered the standard technique in mediastinal lymph node biopsy [3, 16]. EBUS-TBNA has a high diagnostic yield with minimized invasiveness and reduced surgical complications [1, 3, 17–19]. Although a number of large-scale studies did not find complications associated with EBUS-TBNA [3], infectious complications have emerged as an issue with the increasing use of this procedure. In a Japanese survey, the frequency of infectious complications was reportedly 0.19% [20]. In particular, mediastinitis after EBUS-TBNA was reported in 0.10% of the cases [20]. To date, only 16 cases of infective mediastinitis after EBUS-TBNA have been reported (Table 1), but this apparently low rate of infection may be due to underreporting. The cases involved 14 men and 2 women with a mean age of 62.3 years (standard deviation (SD) = 14.2). Symptoms of mediastinitis occurred at a mean of 18.1 days (SD = 14.2) after EBUS-TBNA. In some cases, the symptoms manifested relatively late post-procedure, probably due to the small number of inoculating organisms. Clinical vigilance is necessary for an extended period after the intervention.
Table 1

Case list of mediastinitis caused by endobronchial ultrasound-guided transbronchial needle aspiration

AgeSexLapsed daysBacteria of causeDiagnosis by EBUSSurgical procedureRef.
73M11N.P.LN metastasis of lung cancerN.P.4
59M7N.P.LN metastasis of lung cancerN.P.5
68M60 Streptococcus viridans LN metastasis of hepatocellular carcinomaThoracotomy6
75M9 Streptococcus intermedius Nonspecific inflammatory changeMedian sternotomy7
48M6No bacteriaLN metastasis of lung cancerThoracotomy8
68M35 Candida albicans, gamma-hemolytic Streptococcus LN metastasis of colon cancerEBUS-guided aspiration9
66M14 Propionibacterium acnes, Bacteroides, Eubacterium Undifferentiated, malignant cellsThoracotomy9
64F8N.P.LN metastasis of lung cancerN.P.10
72M10Group C Streptococcus LN metastasis of lung cancerThoracotomy11
42M21No bacteriaSarcoidosisMediastinoscopy12
89F14Alpha-hemolytic Streptococcus, diphtheroidsNonspecific inflammatory changeThoracotomy13
48M31 Klebsiella pneumoniae Nonspecific inflammatory changeThoracotomy14
64M16No bacteriaLN metastasis of lung cancerThoracotomy15
49M14 Gemella morbillorum SarcoidosisMediastinotomy15
36M26 Prevotella buccae, Streptococcus anginosus, Actinomyces SarcoidosisThoracotomy15
75M7 Streptococcus pneumoniae Mediastinal lung cancerThoracotomyOur case

F female, M male, N.P. not performed, LN lymph node, Ref. reference

Case list of mediastinitis caused by endobronchial ultrasound-guided transbronchial needle aspiration F female, M male, N.P. not performed, LN lymph node, Ref. reference Surgery was performed in 12 of the 16 cases, and in 9 of these cases, thoracotomy was required. The most common treatment is thoracotomy with chest tube drainage and intravenous antibiotics [6, 8, 9, 11, 13–15]. In 4 cases, intravenous antibiotics alone were administered for 7 to 30 days and surgical debridement was unnecessary [4, 5, 9, 10]. The indication for the procedure was malignancy in 10 cases, particularly lymph node metastasis of lung cancer in 6 cases [4, 5, 8, 10, 11, 15]. In addition, the indications were sarcoidosis in 3 cases [12, 15] and nonspecific inflammatory changes in another 3 [7, 13, 14]. The implicated bacteria were of oropharyngeal origin, e.g., Klebsiella pneumonia [14], Actinomyces [15], hemolytic Streptococcus [9, 13], and Streptococcus intermedius [7]. No bacteria were detected in 3 cases, and the early administration of antibiotics eliminated the infectious pathogens. In all of the reported cases, mediastinitis resolved. The case we reported is the first instance of mediastinal lung cancer complicated by mediastinitis. The presumed mechanism underlying the infectious complications is the introduction of oropharyngeal bacteria into deep mediastinal tissues during the transbronchial or transtracheal passage of the needle [21, 22]. In line with this theory of pathogenesis, S. pneumoniae, a common oropharynx contaminant, was identified as the culprit pathogen in the present case. In contrast, mediastinoscopy via a percutaneous approach is thought to be unlikely to cause infection with oropharyngeal bacteria. However, mediastinoscopy may be associated with other potentially catastrophic complications, such as bleeds due to major vessel damage, tracheobronchial injury, and esophageal trauma [16]. Several recent systematic reviews have reported the diagnostic accuracy of EBUS-TBNA is similar to mediastinoscopy with a significantly lower complication rate [23-25]. Matsuoka et al. suggested that biopsy needle puncture increases the risk of mediastinitis [11]. Infectious complications may be more likely after EBUS-TBNA on necrotic lesions because of compromised bacterial clearance. Based on previous reports of infectious complications after EBUS-TBNA, we suggest that in the case of necrotic lesions, EBUS-TBNA should be performed with great caution and prophylactic antibiotics need to be considered [8, 21, 26]. The antibiotics used in cases of clinically suspected infection must have activity against endogenous oral and nasopharyngeal organisms. Since there is no consensus on the use of prophylactic antibiotics for EBUS-TBNA at present, further investigation is needed. Because mediastinitis after EBUS-TBNA is rare, the diagnosis is sometimes difficult. However, mediastinitis should be considered in the differential diagnosis because of its potentially fatal course. Mild mediastinitis is treatable with antibiotics alone, whereas surgical intervention should be considered without delay in more serious cases [4]. In our case, surgery was chosen immediately after the antibiotic treatment proved ineffective and severe mediastinitis was successfully treated with surgical drainage. In addition, mediastinal lung cancer was diagnosed using surgical biopsy, so that the patient was able to immediately start chemoradiotherapy. As a result, chemoradiotherapy, which is the gold standard of care in mediastinal lung cancer, was successful and the outcome favorable to date. This may be another valuable benefit of the performance of surgery.

Conclusions

The present case underscores the risk of infectious complications after EBUS-TBNA. Close monitoring for the development of signs and symptoms of infection following EBUS-TBNA is essential. Surgery is the treatment of choice for an intractable mediastinal abscess, such as the case reported here.
  26 in total

1.  A serious mediastinum abscess induced by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): a case report and review of the literature.

Authors:  Hiroshi Ishimoto; Kazuhiro Yatera; Keigo Uchimura; Keishi Oda; Masaru Takenaka; Toshinori Kawanami; Fumihiro Tanaka; Hiroshi Mukae
Journal:  Intern Med       Date:  2015-10-15       Impact factor: 1.271

Review 2.  Mediastinal Staging: Endosonographic Ultrasound Lymph Node Biopsy or Mediastinoscopy.

Authors:  Pravachan V C Hegde; Moishe Liberman
Journal:  Thorac Surg Clin       Date:  2016-08       Impact factor: 1.750

3.  Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate.

Authors:  Anthony Lemaire; Ivana Nikolic; Thomas Petersen; Jack C Haney; Eric M Toloza; David H Harpole; Thomas A D'Amico; William R Burfeind
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

4.  Mediastinal Infection After Ultrasound-guided Needle Aspiration.

Authors:  Oleg S Kouskov; Francisco Aécio Almeida; Georgie A Eapen; Mateen Uzbeck; Mark Deffebach
Journal:  J Bronchology Interv Pulmonol       Date:  2010-10

5.  Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis.

Authors:  M Wong; K Yasufuku; T Nakajima; F J F Herth; Y Sekine; K Shibuya; T Iizasa; K Hiroshima; W K Lam; T Fujisawa
Journal:  Eur Respir J       Date:  2007-03-01       Impact factor: 16.671

6.  EBUS-TBNA in elderly patients with lung cancer: safety and performance outcomes.

Authors:  Matthew Evison; Philip A J Crosbie; Julie Martin; Paul Bishop; Helen Doran; Leena Joseph; Anshuman Chaturvedi; Philip V Barber; Richard Booton
Journal:  J Thorac Oncol       Date:  2014-03       Impact factor: 15.609

Review 7.  Mediastinal abscess after endobronchial ultrasound-guided transbronchial needle aspiration: a case report and literature review.

Authors:  Steven C Leong; Henry M Marshall; Michael Bint; Ian A Yang; Rayleen V Bowman; Kwun M Fong
Journal:  J Bronchology Interv Pulmonol       Date:  2013-10

8.  Mediastinal Abscess Following Endobronchial Ultrasound Transbronchial Needle Aspiration in a Patient With Sarcoidosis.

Authors:  Frederic McGovern Murphy; Brian Grondin-Beaudoin; Yannick Poulin; Robert Boileau; Elaine Dumoulin
Journal:  J Bronchology Interv Pulmonol       Date:  2015-10

9.  Mediastinitis: A Serious Complication of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration.

Authors:  Nina Voldby; Birgitte H Folkersen; Torben R Rasmussen
Journal:  J Bronchology Interv Pulmonol       Date:  2017-01

10.  Mediastinitis and pericarditis after endobronchial ultrasound-guided transbronchial needle aspiration.

Authors:  Kentaro Fukunaga; Satoru Kawashima; Ruriko Seto; Hiroaki Nakagawa; Masafumi Yamaguchi; Yasutaka Nakano
Journal:  Respirol Case Rep       Date:  2014-12-24
View more
  4 in total

1.  Severe Mediastinal Abscess after Endobronchial Ultrasound with Transbronchial Needle Aspiration.

Authors:  Jing-Hong Dai; Lu-Lu Chen; Hui Li; Li-Yun Miao; Rui Li; Li Gao; Fan-Qing Meng; Hou-Rong Cai
Journal:  Chin Med J (Engl)       Date:  2018-02-05       Impact factor: 2.628

2.  Development of mediastinal adenitis six weeks after endobronchial ultrasound-guided transbronchial needle aspiration.

Authors:  Sho Shimada; Haruhiko Furusawa; Toshihisa Ishikawa; Eisaku Kamakura; Takafumi Suzuki; Yuta Watanabe; Takasato Fujiwara; Shinichiro Tominaga; Keiko Mitaka Komatsuzaki; Ichiro Natsume
Journal:  Respir Med Case Rep       Date:  2018-08-25

3.  Severe mediastinitis and pericarditis after endobronchial ultrasound-guided transbronchial needle aspiration: A case report.

Authors:  Jeong Suk Koh; Yoon Joo Kim; Da Hyun Kang; Jeong Eun Lee; Song-I Lee
Journal:  World J Clin Cases       Date:  2021-12-06       Impact factor: 1.337

4.  Mediastinal cyst infection followed by bacteremia due to Streptococcus anginosus after endobronchial ultrasound-guided transbronchial needle aspiration.

Authors:  Takehiko Hashimoto; Masaru Ando; Erina Watanabe; Jun-Ichi Kadota
Journal:  Ann Thorac Med       Date:  2020-04-03       Impact factor: 2.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.